With the identification of several mutations within the MMR genes (MLH1, MSH2, MSH6, and PMS2), the National Cancer Institute held an International Workshop on Lynch syndrome in Bethesda in November, 1997 [13]. The gene discussed is MSH6; the disease is Lynch syndrome.